Sironax Overview

  • Founded
  • 2017

Founded
  • Status
  • Private

  • Employees
  • 180

Employees
  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $200M

  • Investors
  • 22

Sironax General Information

Description

Developer of pharmaceuticals for inflammatory and neuro-degenerative diseases. The company researches apoptosis and other cell death pathways to develop quality pharmaceuticals, enabling healthcare professionals to prescribe advanced treatments to their patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • Floor 8-10, Building 2, Medical Technology Center Phase II
  • Zhongguancun Life Science Park, Changping District
  • Beijing, 102206
  • China
+86 010 0000 0000

Sironax Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sironax Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series B) 02-Aug-2022 $200M 00000 Completed Clinical Trials - General
2. Early Stage VC (Series A) 30-Sep-2019 00000 00000 Completed Clinical Trials - General
1. Seed Round 01-Jun-2018 $15M $15M Completed Startup
To view Sironax’s complete valuation and funding history, request access »

Sironax Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of pharmaceuticals for inflammatory and neuro-degenerative diseases. The company researches apoptosis and othe
Drug Discovery
Beijing, China
180 As of 2022
00000
00000000000 00000

000000

nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. D
0000 000000000
South San Francisco, CA
000 As of 0000
00000
000000 - 000 00000

000000

ation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure d
0000 000000000
New York, NY
00 As of 0000
000.00
00000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sironax Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Alector Formerly VC-backed South San Francisco, CA 000 00000 000000 - 000 00000
000000000 00000000 Formerly VC-backed New York, NY 00 000.00 00000000 000.00
000000 00000000000 Corporation Toronto, Canada 0 000.00 000000000 000.00
You’re viewing 3 of 3 competitors. Get the full list »

Sironax Patents

Sironax Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021275829-A1 Azetidine cyclic ureas Pending 20-May-2020 0000000000
CA-3183668-A1 Azetidine cyclic ureas Pending 20-May-2020 0000000000
CA-3183676-A1 Piperazine cyclic ureas Pending 20-May-2020 0000000000
CA-3183661-A1 Receptor-interacting protein 1 inhibitors including piperazine heterocyclic amide ureas Pending 20-May-2020 0000000000
CA-3174992-A1 Ferroptosis inhibitors - diarylamine para-acetamides Pending 02-Mar-2020 C07C259/06
To view Sironax’s complete patent history, request access »

Sironax Executive Team (4)

Name Title Board Seat Contact Info
Gang Ren Ph.D Chief Executive Officer
Zhiyuan Zhang Ph.D Senior Scientific Consultant & Founder
Liwen Hou Controller, Senior Director of Finance
Xiaodong Wang Ph.D Chairman & Co-Founder
To view Sironax’s complete executive team members history, request access »

Sironax Board Members (1)

Name Representing Role Since
Xiaodong Wang Ph.D Sironax Chairman & Co-Founder 000 0000
To view Sironax’s complete board members history, request access »

Sironax Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sironax Investors (22)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Abu Dhabi Investment Authority Sovereign Wealth Fund Minority 000 0000 000000 0
CBC Group PE/Buyout Minority 000 0000 000000 0
Future Innovation Fund Venture Capital Minority 000 0000 000000 0
Gaorong Capital Venture Capital Minority 000 0000 000000 0
Invus Opportunities Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 22 investors. Get the full list »